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Summary. This study analyzed the expression of stress- 
response (heat-shock) protein 60 (srp 60) in a series of 
158 human brain tumours. Immunohistochemical 
procedures were employed; cells of the human cervical 
cancer line HeLa S3 exposed to hyperosmolar stress 
served as positive controls. Deposits of reaction products 
were found in the cytoplasm. Approximately half of the 
glioblastomas multiforme (17/31), breast carcinoma 
metastases (6/10), and lung carcinoma metastases (5111) 
as well as about one-third of the astrocytomas (5113) and 
meningiomas (8123) had tumour cells that expressed srp 
60. A positive reaction for srp 60 was also seen in some 
medulloblastomas (2/16), primitive neuroectodermal 
tumours (PNETs) (2/11), schwannomas (2121), and 
pituitary adenomas (2/7), but no positive reactions were 
observed with oligodendrogliomas and ependymomas. 
Compared with srp 60-negative tumours, srp 60-positive 
tumours coexpressed one or more stress-related proteins, 
among which srp 90, srp 72, srp 27, alphaB-crystallin 
and ubiquitin occurred with higher frequencies; a high 
correlation between srp 60 and the other five srps (0.88 - 
0.97, pe0.01, Pearson correlation coefficient) was 
observed in srp 60-positive tumours. In contrast, the 
correlation coefficient in srp 60-negative tumours was 
not significant (-0.26 - 0.71). There was a tendency for 
the proliferating cell nuclear antigen (PCNA)-labeling 
index to be higher in glioblastomas, astrocytornas, 
medulloblastomas, PNETs, and breast and lung 
carcinoma metastases that expressed srp 60 than in those 
that did not. No significant immunohistochemical 
reactions of srp 60, PCNA and p53 protein were seen 
with sections of normal brain tissues. We conclude that 
primary and metastatic tumours of the brain produce srp 
60 and that srp 60 in certain brain tumour cells may 
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coexpress the other five srps. In addition, srp 60 
expression might depend, in part, on proliferating 
potential. 
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lntroduction 
Under various conditions of harmful stresses, stress- 
response proteins (srps) are induced in prokaryotic and 
eukaryotic species, as a means for protection (Lindquist 
and Craig, 1988; Morimoto et al., 1990; Ellis and van 
der Vies, 1991). There have been extensive studies to 
evaluate the physiological significance of these srps in 
the maintenance of cell integrity at the cellular level 
(Lindquist and Craig, 1988; Morimoto et al., 1990; Ellis 
and van der Vies, 1991). These srps are classified into 
different families according to their apparent molecular 
mass. The srp 60 kDa family (srp 60), which retains an 
uniquely high level of sequence conservation during 
evolution, is expressed in response to severe 
circumstances at the cellular level (Jindal et al., 1989; 
Itoh et al., 1995). 
Recently, srp 60 has been considered to be involved 
in the pathogenetic mechanism of autoimmune diseases 
(Lanks, 1986; Haregewoin et al., 1989, 1991; Selmaj et 
al., 1991, 1992; Boog et al., 1992; Lohse et al., 1993; 
Brosnan et al., 1996). Srp 60 is reported to develop in 
the target tissues of autoimmune diseases such as 
synovial membranes in juvenile chronic arthritis (Boog 
et al., 1992), oligodendrocytes in multiple sclerosis 
(Selmaj et al., 1991, 1992; Brosnan et al., 1996) and 
hepatocytes in autoimmune hepatitis (Lohse et al., 
1993). Furthermore, srp 60 is thought to be one of the 
epitopes of gamma delta T lymphocytes that play an 
important role in immune responses (Lanks, 1986; 
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Haregewoin et al., 1989, 1991). When srp 60 is induced 
to protect the self structure from harmful stresses, the 
gamma delta T lymphocytes recognize the srp 60 as an 
antigen (Haregewoin et al., 1989, 1991). These gamma 
delta T cells attack the target cells expressing srp 60 as 
well as the activated alpha beta T cells, resulting in 
persistent inflammation; i.e., an autoimmune 
inflammation (Collins and Hightower, 1982;  
Haregewoin et al., 1989, 1991; Selmaj et al., 1991, 1992; 
Boog et al., 1992; Ferm et al., 1992; Lohse et al., 1993; 
Xu et al., 1994; Kato et al., 1995; Brosnan et al., 1996; 
Martins et al., 1996). 
Among the primary brain tumours, glioblastoma 
multiforme (GBM) is one of the most malignant tumours 
(Kleihues et al., 1993; Lantos et al., 1997). This type is 
histologically characterized by pseudopalisading around 
areas of tumour necrosis, mitotic activity, poorly 
differentiated fusiform cells, pleomorphic cells including 
multinucleated giant cells, vascular proliferation 
including endothelial proliferation, and often 
mononuclear cell infiltration including perivascular 
lymphocytic cuffing. The lymphocytic cuffing, which 
predominantly consists of T cells, may represent the host 
immune system's immune response to GBM cells 
(Lantos et al., 1997). Lymphocytic cuffing is thought to 
be a disadvantageous response to the GBM cells 
themselves: there are some reports that the GBM 
patients with lymphocytic cuffing have a better 
prognosis compared to the GBM patients without the 
lymphocytic cuffing (Brooks et al., 1978; Palma et al., 
1978). However, other researchers failed to note any 
correlation with patient survival (Burger and Vollmer, 
1980; Ito et al., 1994). It has even been reported that the 
presence of mononuclear cell infiltration in malignant 
glioma is associated with a poor prognosis (Safdari et 
al., 1985). To date, little is known about the exact 
mechanism of the mononuclear cell infiltration in GBM. 
Although GBMs cannot readily be compared with 
autoimmune diseases such as juvenile arthritis, multiple 
sclerosis and autoimmune hepatitis, the perivascular 
lymphocytic cuffing o b s e ~ e d  in GBMs leads us to the 
notion that GBM cells in the vicinity of this cuffing 
would express srp 60. Based on these considerations, we 
Table 1. Primaty antibodies used in this study. 
have carried out retrospective immunohistochemical 
studies on srp 60 expression in GBMs, comparing the 
results with those obtained from other tumours of the 
central nervous system (CNS) including metastatic brain 
tumours. Moreover, to gain insight into the biological 
significance of srp 60 expression in brain tumour cells, 
comparative immunohistochemical studies were carried 
out to characterize the expression of the other srp 
families (srp 90, srp 72, srp 27, alphaB-crystallin, and 
ubiquitin), proliferating cell nuclear antigen (PCNA) and 
p53 protein in these tumours. 
Materials and rnethods 
Tissue collection 
This retrospective study was carried out on biopsy 
samples of 137 primary brain tumours, biopsy specimens 
of 10 CNS metastatic breast carcinomas, and autopsy 
samples of 11 CNS metastatic lung carcinomas. The 
tumour tissues were fixed in 10% phosphate-buffered 
formalin (pH 7.4) and then embedded in paraffin. The 
brain tumours were classified according to the WHO 
Histological Classification of Tumours (Kleihues et al., 
1993). Eight of the 14 astrocytomas were fibrillary, 3 
were protoplasmic, and 3 were pilocytic. Of the 11 
primitive neuroectodermal tumours (PNETs) examined, 
9 were located in the cerebrum and 2 in the spinal cord. 
Of the 20 meningiomas studied, 10 were classified as 
meningotheliomatous, 4 as fibroblastic, 5 as transitional, 
and 1 as  psammomatous. We examined autopsy 
specimens of brain tissues (cerebral cortex, basa1 
ganglia, thalamus, white matter, brain stem, cerebellum, 
and spinal cord), as well as pituitary glands from 20 
neurologically and neuropathologically normal 
individuals (aged 15-75 years [yr]). 
Histopathology and immunohistochemistry 
As a control, we included cells of the continuous 
human cervical tumour line HeLa S3 (Herz et al., 1977; 
Hatayama et al., 1986; Rattner, 1991). Two types of 
cultures were examined: cells grown in regular medium 
SOURCE (REFERENCE) 
Stress-response protein 60 
Stress-response protein 90 
Stress-response protein 72 
Stress-response protein 27 
AlphaB-crystallin 
Ubiquitin 
p53 Protein 
Proliferating cell nuclear antigen 
CD45RO 
CD20 
CD68 
Clone LK-1 ; StressGen. Victoria, Canada 
Clone 386; Affinity BioReagents, Neshanic Station, NJ, USA 
Code RPNI 197; Amersham, Little Chalfont, UK 
Clone G3.1; BioGenex, San Roman, CA, USA 
Dr. J.E. Goldman (Iwaki et al., 1989, 1990) 
Dr. S.-H. Yen (Lee et al., 1989) 
Clone DO-1; Oncogene Science, Uniondale, NY, USA 
Clone PC10; Oncogene Science, Uniondale, NY, USA 
Clone UCHLI; Nichirei, Tokyo, Japan 
Clone L26; Nichirei. Tokyo, Japan 
Clone PG-MI; Dako, Glostrup, Denmark 
M: monoclonal; P: polyclonal. 
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and cells grown under conditions of hyperosmolar stress 
(Kato et al., 1992a). Eagle's minimum essential medium 
containing 10% fetal bovine serum was used. Cells were 
grown in chamber slides (Herz et al., 1985; Kato et al., 
1992a) and the osmolality of one set of cultures was 
increased from 290 mOsm/kg to 490 mOsm/kg by the 
addition of 100 mM NaCl (from an autoclaved 3 M 
stock solution) 24 hours (h) after cell transfer. The cell 
monolayers were fixed 72 h later and stored before use 
at 4 OC in phosphate-buffered saline, pH 7.4 (PBS). 
Multiple sequential sections (6-micrometers-thick) 
were prepared from each specimen. One section was 
stained with haematoxylin and eosin (H&E) and the 
others were employed in the immunohistochemical 
assays. The sources of the primary antibodies and the 
dilutions used are listed in Table 1. Sections were 
deparaffinized, endogenous peroxidase activity was 
quenched by incubation for 30 minutes (min) with 0.3% 
H202 and then they were washed in PBS. Normal sera 
homologous with the secondary antibody were used as 
blocking reagents. Tissue sections were incubated with 
the antibodies listed in Table 1 for 18 h at 4 "C. Only the 
HeLa S 3  cell monolayers were incubated with the 
antibody against srp 60. Sections exposed to PBS served 
as controls. With respect to the preabsorption test, some 
sections and HeLa S3 cell monolayers were incubated 
with anti-srp 60 antibody that had been preabsorbed with 
an excess of the recombinant human srp 60 antigen 
(StressGen, Victoria, Canada). Bound antibodies were 
visualized by the avidin-biotin-immunoperoxidase 
complex (ABC) method using the appropriate Vectastain 
ABC kits (Vector Laboratories, Burlingame, CA, USA) 
and 3,3'-diaminobenzidine tetrahydrochloride (DAB) as 
chromogen. In some sections and some HeLa S3  cell 
monolayers, methyl green was used as counterstain. 
The labeling of two antigens in the same tissue 
section was also performed. After the visualization of 
the first immunoreaction products by the ABC method 
using DAB as a brown chromogen, the DAB sections 
were rinsed in PBS and twice incubated for 60 min at 
room temperature with glycine-hydrochloric acid buffer 
solution (pH 2.2) to elute the bound antibody. The 
completeness of the elution process was verified by 
obtaining a negative reaction after repeating the 
immunohistochemical assay with the appropriate ABC 
kit employing a secondary antibody and 3-amino-9- 
ethylcarbazole (AEC) (red, Vector) as chromogen on the 
eluted sections. Subsequently, the sections were rinsed 
with PBS and incubated with normal sera homologous 
with the secondary antibody as blocking reagents. These 
sections were treated with an avidin-biotin blocking kit 
(Vector), incubated with the second primary antibody for 
1 8  h at 4 "C, and then the immunoreactivity was 
visualized by the ABC method using Vector S G  
(greyblue, Vector). 
For the assessment of PCNA immunostaining, only 
neoplastic areas delineated by the histological features 
seen on contiguous, H&E-stained serial sections were 
evaluated; 1,000 tumour cells from the randomly 
selected high power f ields (x400) were counted, 
excluding the areas with excessive or  scant 
immunostaining. Al1 neoplastic cell nuclei stained by the 
respective primary antibody were considered to be 
PCNA-positive. The PCNA-labeling index (LI) was 
expressed as the percentage of PCNA-positive tumour 
cell nuclei. The p53 immunoreaction was considered to 
be positive when the cell  nuclei were stained, 
irrespective of the percentage of positive cells. Al1 
procedures were performed blind by two observers. Each 
was analyzed by the Fisher exact test, Wilcoxon rank- 
sum test, and Pearson correlation coefficient. 
Results 
When representative paraffin sections and HeLa S3 
cell monolayers were incubated with PBS, no staining 
was detected. In addition, the anti-srp 60  antibody 
pretreated with an excess of the recombinant human srp 
60 antigen did not stain sections or HeLa S3  cells with 
any immunoreaction products. No significant reaction 
was seen with normal human brains and the other 
normal nervous tissues examined. 
Although s rp  60-positive HeLa S 3  cells were 
detected in cultures grown in regular medium, the 
staining intensity of stained cel ls  was  not very 
pronounced (Fig. la). As was to be expected (Stege et 
al., 1995), the staining intensity of srp 60-positive cells 
in cultures grown under hyperosmolar conditions was 
greater than that in cells grown in regular medium: the 
deposits of reaction products were found in the 
cytoplasm (Fig. lb). 
The staining intensity and proportion of positively- 
stained versus unstained tumour cells varied from 
sample to sample. Cytoplasmic staining with anti-srp 60 
antibody was observed in 17 of the 31 GBMs (Figs. 2, 
3). Table 2 listed the frequencies of s rp  60  
immunoreactivity and perivascular cuffing among the 31 
specimens with GBMs. In 13 (41.9%) of the 31 GBMs 
examined, perivascular cuffing was evident. Whether the 
occurrence of perivascular cuffing coincided with srp 60 
immunoreactivity was determined by the Fisher exact 
test, yielding a probability of 0.1582. Statistically, the 
presence of perivascular cuffing was not more common 
in GBM specimens with srp 60-positive tumour cells as 
compared to those with srp 60-negative cells: there was 
no specific linkage between the srp 60 expression and 
the presence of perivascular cuffing. Even in srp 60- 
Table 2. Relationship between stress-response protein (srp) 60 
immunoreactivity and perivascular cuifing in 31 specimens in patients 
with glioblastomas multiforme. 
SRP 60 IMMUNOREACTIVITY TOTAL 
Positive Negative 
Perivascular cuffing 9 4 13 
No perivascular cuffing 8 10 18 
Total 17 14 31 
Flg. 1. lmmunocytochemical demonstration of stress-response protein (srp) 60 in the human cervical tumour cell line HeLa S3. a. Srp 60 of cells grown 
in regular medium; some cells are positively stained. b. Srp 60 of cells grown for 72 h in hyperosrnolar rnedium. The number of positive cells is 
increased and staining intensity is greater than in cells in regular medium (a). Counterstained with methyl green. x 725 
Fig. 2. Light micrograph of a glioblastoma multiforme. Section stained by double-labeling with antibody against srp 60 (LK-1) using Vector SG 
(greylblue) and antibody to proliferating cell nuclear antigen (PCNA) (PC10) using 3,3'-diaminobenzidine tetrahydrochloride (DAB) (brown). 
Cytoplasmic staining with anti-srp 60 antibody (greylblue) is obsewed in many tumour cells, and nuclear staining with anti-PCNA antibody (brown) is 
also seen. Over 30% of the turnour cells are intensely stained by anti-srp 60 antibody, and this turnour shows a high PCNA-labeling index, with an 
average of 49.0%. Many srp 60-positive tumour cells have PCNA-positive nuclei (large arrows), but sorne srp 60-positive cells have PCNA-negative 
nuclei (small arrows). No wunterstaining. x 545 
Flg. 3. Light micrograph of a glioblastoma multiforme. Double labeling technique using anti-srp 60 antibody (brown) and anti-CD45RO antibody 
(UCHL1) (greylbrown). Srp 60-positive tumour cells (arrows) are ObSe~ed not only at the marginal region of the CD45RO-positive cell (T cell) infiltration 
(arrowheads) but also at the distant region from the CD45RO-positive cell infiltration. No wunterstaining. x 150 
Expression of srp 60 in brain tumours 
Flg. 4. Serial 
sections (a-d) of 
perivascular 
cufñng in a 
glioblastoma 
multiforme. 
Perivascular 
cuíñng mainly 
consists of 
mononuclear 
celis (a). A 
predominance of 
CD45RO 
(UCHL1)-positive 
cells (T cells) can 
be obsewed @). 
CD68 (PG-MI)- 
positive cells 
(macrophages) 
cannot be seen in 
this cuiíing (c), 
but CD20 (L26)- 
posRive cells (6 
cells) are present 
in smaller 
numbers (d). 
a, Haematoxylin 
and eosin, x 235; 
b, CD45R0, No 
counterstaining, 
x 235; 
c, CD68, No 
counterstaining, 
x 235; 
d, CD20, No 
counterstaining, 
x 235 
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Table 3. Relationship of stress-response protein (srp) 60 to the other five srps (srp 90, srp 72, srp 27, alphaB-crystallin and ubiquitin), p53 protein, and 
proliferating cell nuclear antigen labeling index (PCNA-LI) in 137 primary brain tumours and 21 brain metastases. 
DIAGNOSIS Srp 60 Srp 90 Srp 72 Srp 27 aBC Ubi P53 PCNA-LI 
(+) (-1 (+) (+) (+) (+) (+) (+) (%)* 
GBM 17(54.8%) 1 O 1 O 11 13 7 13 24.813.3 
[311 14 3 2 6 7 O 1 O 18.1 11 .8 
Ast 5(38.5%) 3 1 1 4 1 2 1.5I0.6 
[I 31 8 3 2 O 2 O 3 1.3I0.6 
Olig o(@% 0 0 0 0 0 0 0 
[1 01 1 O O O O O O 3 1.710.5 
Epen o(o%) O O O O O O O 
151 5 1 1 1 3 O 3 2.5I0.9 
Med 2(12.5%) 2 2 O 1 O 1 27.2,40.1 
[161 14 1 O 1 2 O 4 17.412.5 
PNET 2(18.2%) 1 1 1 1 O O 23.4,39.0 
11 11 9 1 1 1 O O 1 16.613.0 
Schw 2(9.5%) 1 1 2 2 O 1 1.3, 1.6 
[211 19 1 1 16 14 1 8 1.310.2 
Men 8(34.8%) 6 7 5 1 1 2 1.5I0.3 
1231 15 5 6 2 O 1 6 1.410.6 
Pt- Ad 2(28.6%) O 1 2 O 1 O 0.3, 1 .8 
m 5 O 1 O 1 O 1 1.210.4 
Br-Mt 6(60.0%) 4 6 6 2 2 2 26.515.2 
[lo] 4 1 2 2 O 1 2 21.617.9 
L-Mt 5(45.5%) 2 2 3 O 1 2 1 1.613.9 
11 11 6 O O O O 2 2 9.0I2.3 
Srp 90: Stress-response protein 90; Srp 72: stress-response protein 72; Srp 27: stress-response protein 27; aBC: alphaB-crystallin; Ubi: ubiquitin; p53: 
p53 protein; PCNA-LI: proliferating cell nuclear antigen labeling index. (+): positive; (-): negative. GBM: glioblastoma multiforme; Ast: astrocytoma; Olig: 
oligodendrogliorna; Epen: ependyrnoma; Med: medulloblastoma; PNET: primitive neuroectodermal tumour; Schw: schwannoma; Men: meningioma; Pt- 
Ad: pituitary adenoma; Br-Mt: breast carcinoma metastasis; L-Mt: lung carcinoma rnetastasis. *: values each represent a mean I standard error of the 
mean. The total nurnber of each tumour type is in brackets. For each type of tumour, the percentage expressing a given protein is in parentheses. 
Table 4. Comparison of the expression of stress-response protein (srp) 60 and proliferating cell nuclear antigen labeling index (PCNA-LI) in srp 60- 
positive prirnary and metastatic brain tumours. 
DIAGNOSIS PERCENTAGE OF SRP 60- POSITIVE TUMOR CELLS PCNA-LI RANGE (%) 
~ 1 5 %  15-30% >30% 
Glioblastoma 
multiforme 
Astrocytoma 
Medulloblastoma 
Primitive 
neuroectodermal tumour 
Schwannoma 
Meningioma 
Piuitary adenoma 
Breast cancer 
metastasis 
Lung cancer 4 2.1-1 7.7 (9.0) 
metastasis 1 22 
a: the mean value of the PCNA-LI of given tumours is in parentheses. 
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positive specimens with CD45RO-positive cell (T cell) 
infiltration, srp 60-positive tumour cells were observed 
not only at the marginal regions of the CD45RO-positive 
cell infiltration but also at the distant regions from 
CD45RO-positive cell infiltration (Fig. 3). Namely, srp 
6 0  expression and the perivascular cuffing were 
independent of each other. Immunohistochemical results 
of the perivascular mononuclear cell  phenotypes 
revealed that a predominante of CD45RO-positive cells 
(T cells) was generally observed and that CD68-positive 
cells (macrophages) and CD20-positive cells (B cells) 
appeared to be present in smaller numbers (Fig. 4a-d). 
The results on 137 primary brain tumours and 21 
carcinoma metastases to the CNS are summarized in 
Table 3. Approximately half of the GBMs (17/31), breast 
carcinoma metastases (6110), and lung carcinoma 
metastases (5111) as well as about one-third of the 
astrocytomas (5113) (Fig. 5) and meningiomas (8123) 
had tumour cells that expressed srp 60. An srp 60- 
positive reaction was also seen in some 
medulloblastomas (2116) (Fig. 6), PNETs (2/11), 
schwannomas (2/21), and pituitary adenomas (2/7), but 
no positive reactions were observed with the 
Fig. 5. lmmunostaining for srp 60 of a protoplasmic astrocytoma. 
Several tumour ceils with a positively-stained cytoplasm can be seen. 
No counterstaining, x 230 
oligodendrogliomas and ependymomas. 
Table 3 also revealed a striking variability with 
respect to expression of the proteins examined. Although 
the staining intensity and proportion of positively- 
stained tumour cells varied, the reaction products with 
the antibodies to srp 60, srp 90, srp 72, srp 27 and 
alphaB-crystallin were seen only in the cytoplasm; 
patchy staining patterns were observed in the specimens, 
including those with cytoplasmic staining for ubiquitin. 
No significant immunoreactivity with respect to p53 was 
seen in normal brain tissues. In contrast, the brain 
tumour specimens were stained by the antibody to p53 
protein; granular or diffuse reaction product deposits 
were seen. However, the staining intensity varied from 
one tumour cell to another. Normal brain tissues were 
consistently negative for PCNA. By comparison, diffuse 
or granular nuclear staining was observed in the tumour 
tissues, with the reaction intensity varying among the 
PCNA-positive cells. 
Only the oligodendrogliomas failed to be 
immunostained by the anti-srp 60 antibody as well as the 
other antibodies against srp 90, srp 72, srp 27, alphaB- 
Fig. 6. lmmunostaining for srp 60 of a medullobiastoma. The cytoplasm 
of the tumour cells is positively stained. The stainlng lntensity varies 
from one tumour cell to another. Some tumour cells are intensely 
stained (arrowheads), but others are weakly stained (arrows). Weakly 
counterstained with methyl green, x 230 
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srp 60 (+) case (n) 
Flg. 7. Correlation between srp 60 and the other five srps (srp 90, srp 
72, srp 27, alphaB-crystallin or ubiquitin) in srp 60-positive samples (a) 
and in srp 60-negative samples (b). a. In the srp 60-positive group, a 
high correlation between srp 60 and the other h e  srps is Obce~ed. Srp 
60 and srp 90 data (open circles): Pearson correlation coefficient (r) = 
0.97, y = 0.62~ - 0.1 1, p c 0.01. Srp 60 and srp 72 data (open triangles): 
r = 0.92, y = 0.63~ + 0.02, p c 0.01. Srp 60 and srp 27 data (open 
squares): r = 0.94, y = 0.65~ - 0.1 0, p<O.Ol. Srp 60 and alphaB-cristallin 
data (aBC, asterisks): r = 0.88, y = 0.69~ - 0.87, pe0.01. Srp 60 and 
ubiquitin data (ubi, open diamonds): r = 0.94, y = 0.39~ - 0.57, pc0.01. 
b. In the srp 60-negative group, the correlation coefficient (-0.26 - 0.71) 
is not significant. (n) = number, (+) = positive, (-) = negative. 
(n) 
crystallin and ubiquitin. Al1 other tumour types had cells 
that were positively stained for one or more srps. Tbe 
proportion of tumour types positively immunostained for 
a given srp varied. When we focused on the srp 60- 
positive tumours in comparison to the srp 60-negative 
tumours, it is evident that the srp 60- positive tumours 
expressed one or more stress-related proteins (Le., srp 
90, srp 72, srp 27, alphaB-crystallin and ubiquitin) with 
higher frequencies. Most notably, the srp 60-positive 
GBMs showed higher expressions of srp 90 (10/13), srp 
72 (10/12), srp 27 (11117), alphaB-crystallin (13120) and 
ubiquitin (717). Quantitatively, similar observations were 
made in breast cancer metastases and lung cancer 
metastases: in the srp 60-positive breast cancer 
metastases, higher frequencies of positive reactions for 
srp 90 (4/5), srp 72 (6/8), srp 27 (6/8), alphaB-crystallin 
(212) and ubiquitin (213) were observed. Likewise, srp 
60-positive lung cancer metastases showed higher 
frequencies of srp 90 (2/2), srp 72 (2/2), srp 27 (313) and 
ubiquitin (113). Namely, a high correlation between srp 
60 and the other five srps (0.88 - 0.97, p<0.01, Pearson 
correlation coefficient) was noted in srp 60-positive 
tumours (Fig. 7a). In contrast, the correlation coefficient 
in srp 60-nagative tumours was not significent (-0.26 - 
0.71) (Fig. 7b). 
Although we could recognize no statistically 
significant relationship between srp 60 expression and 
PCNA-LI in primary and metastatic brain tumours, there 
was a tendency for the PCNA-LI to be higher in GBMs, 
astrocytomas, medulloblastomas, PNETs, breast 
carcinoma metastases and lung carcinoma metastases 
that expressed srp 60 than in those that did not (Table 3). 
Especially, GBMs, medulloblastomas, PNETs, breast 
carcinoma metastases and lung carcinoma metastases 
with a high proportion of cells expressing srp 60 tended 
to have a higher PCNA-LI than those with a low 
proportion of srp 60-positive cells (Table 4). Thus, the 
highest PCNA-LI (41.0% and 49.0%) was seen in the 
two GBMs that had more than 30% srp 60-positive cells. 
Compared with those two GBMs, the 12 GBMs with less 
than 15% srp 60-positive cells had a lower PCNA-LI 
(average 19.2%). No evidence of a relationship between 
srp 60 expression and p53 protein was seen in primary 
and metastatic brain tumours. 
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Adverse physiological and environmental conditions 
cause cells to produce a vanety of ubiquitous and highly 
conserved proteins, collectively called "stress-response 
proteins (srps)" (Lindquist and Craig, 1988; Morimoto et 
al., 1990;  Ellis and van der  Vies, 1991). As a 
consequence, these proteins also present under normal 
conditions, albeit in much smaller amounts, increase and 
accumulate in cells (Lindquist and Craig, 1988; 
Morimoto et al., 1990; Ellis and van der Vies, 1991). 
Much information has accumulated regarding the role of 
srps in cells and tissues subjected to stress (Lindquist 
and Craig, 1988; Morimoto et al., 1990; Ellis and van 
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der Vies, 1991), and a variety of functions has been 
ascribed to them under physiological conditions. They 
include synthesis, assembly and translocation of proteins 
(Chirico et al., 1988; Kang et al., 1990); binding of ATP 
(Milarski and Morimoto et al., 1989); signal transduction 
(Michishita et al., 1991); regulation of cell proliferation 
(Pechan, 1991); and complexing with the nuclear 
phosphoprotein encoded by the tumour suppresser gene 
p53 (Pinhasi-Kimhi et al., 1986; Finlay et al., 1988). The 
role of srps in apoptosis (Schett et al., 2000) and 
tumorigenesis (Soldes et al., 1999) has also reported. 
Among srp families, srp 60 has been shown to be one of 
the critica1 antigens in a number of autoimmune diseases 
(Collins and Hightower, 1982; Lanks, 1986; Haregewoin 
et al., 1989, 1991; Selmaj et al., 1991, 1992; Boog et al., 
1992; Ferm et al., 1992; Lohse et al., 1993; Xu et al., 
1994; Brosnan et al., 1996; Martines et al., 1996). The 
first member of this srp 60 family to be recognized was 
the GroEL protein that was identified as a protein 
essential for the morphogenesis of bacteriophage 
lambda, functioning as a scaffold for the assembly of the 
head and tail whilst not becoming incorporated into the 
final assembled phage (Itoh et al., 1995; Brosnan et al., 
1996). Homologous forms of this protein have been 
identified in most living organisms, but in eukaryotes, 
constitutive expression of srp 60 is principally associated 
with mitochondria where it participates in the folding 
and assembly of transported proteins into the 
mitochondrion in an ATP-dependent manner (Itoh et al., 
1995; Brosnan et al., 1996). 
Monoclonal antibodies that are unique for the 
bacteria1 or mammalian forms of srp 60 have been 
developed, allowing identification of possible sources of 
altered expression of this protein in various disease 
states (Itoh et al., 1995; Brosnan et al., 1996). Especially, 
the monoclonal antibody LK-1 used in this study 
recognizes an epitope located between amino acids 383- 
447 of the human srp 60 sequence (Boog et al., 1992). 
This amino acid sequence does not share homology with 
any subunit of chaperonin containing TCP-1 (CCT) in 
Protein Bank. Together with the fact that srp 60 has been 
reported to be expressed in response to conditions of cell 
stress at the cellular leve1 (Jindal et al., 1989; Itoh et al., 
1995), HeLa S3 cells exposed to hyperosmolar stress 
reacted strongly with the monoclonal antibody LK-1. In 
the CNS tumours found to express srp 60, the stained 
cells were accompanied by tumour cells that failed to 
react with the monoclonal antibody against srp 60. This 
lack of uniformity, also encountered with CNS tumours 
examined for the expression of srp 90 (Kato et al., 
1995), srp 72 (Kato et al., 1992c, 1993), srp 27 (Kato et 
al., 1992b, 1993), alphaB-crystallin (Kato et al., 1993) 
and ubiquitin (Kato et al., 1993), could reflect tumour 
heterogeneity, as well as the possibility that stress is 
being exerted on some, but not al1 the cells of the same 
tumour cell population. Our data that the srp 60-positive 
brain tumours have coexpressed the other five srps with 
higher frequencies are a novel finding suggesting that 
srp 60 in brain tumour cells may function in concert with 
the other srps (90 kDa, 72 kDa, 27 kDa, alphaB- 
crystallin and ubiquitin) in response to stress conditions; 
a high correlation between srp 60 and the other five srps 
(0.88 - 0.97, pc0.01, Pearson correlation coefficient) was 
observed in srp 60-positive tumours. In contrast, the 
correlation coefficient in srp 60-negative tumours was 
not significant (-0.26 - 0.71). This is compatible with the 
Hartl's hypothesis that srp 60 functions in combination 
with the other srps in highly coupled sequential 
chaperone pathways (Hartl and Martin, 1995). 
As for the relationship between srp 60 expression in 
tumour cells and mononuclear cell infiltration including 
T cell lymphocytes, we could not identify a specific 
linkage between the two phenomena. Therefore, the 
possibility has to be considered that increased srp 60 
expression by certain CNS tumour cells may be an 
intrinsic characteristic of some neoplasmic cells. This 
may reflect our finding that HeLa S3 cells constitutively 
expressed srp 60 in regular medium and the staining 
intensity of HeLa S3 cells exposed to hyperosmolar 
shock was amplified. 
PCNA, a 36-kDa non-histone nuclear protein, is 
highly conserved not only in mammals, but also in plants 
(Suzuka et al., 1989). In eukaryotic cells, this protein is 
directly involved in the synthesis of leading strand DNA 
and in DNA repair, acting as a cofactor of DNA 
polymerase-delta (Bravo et al., 1987; Nishida et al., 
1988; So and Downey, 1988). Nuclear accumulation of 
PCNA begins in the late G phase and reaches a 
maximum in the S phase of tbe ceii cycle (Ceiis and 
Celis, 1985). When the expression of PCNA was used as 
an indicator of cell proliferation (Morris and Mathew, 
1989), we did not find that PCNA-LI of srp 60-positive 
primary and metastatic brain tumour cells was 
statistically higher than that of srp 60-negative cells. 
However, there was a tendency for the PCNA-LI to be 
higher in glioblastomas, medulloblastomas, PNETs, and 
metastatic brain tumours that expressed srp 60 in a high 
proportion of cells. In particular, two GBMs that had 
more than 30% srp 60-positive cells also had high 
growth potential. This suggests that srp 60 might play a 
role in the proliferation of diverse brain tumour cells. 
However, each individual tumour cell observation failed 
to demonstrate that al1 srp 60-expressing cells were 
indeed PCNA-positive nuclei-bearing cells, i.e., 
proliferating cells. To conclusively elucidate the 
relationship between srp 60 expression and PCNA 
expression for individual tumour cells, a more complete 
understanding of the molecular mechanism of srp 60 
expression in human brain tumour cells would be 
necessary. 
Wild-type (normal) p53 protein is a 53 kDa, 393 
amino acid nuclear phosphoprotein that functions as a 
check point controller in the G1 phase of the cell cycle in 
response to DNA damage (Lane, 1992; Louis, 1994). 
The human p53 gene is located on chromosome 17p13.1 
(Benchimol et al., 1985). Deletion of one allele (loss of 
heterozygosity) is associated with human brain tumours 
(el-Azouzi et al., 1989; Fultz et al., 1989; James et al., 
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1989;  Nigro e t  al., 1989;  Frankel e t  al., 1992). 
Furthermore, the normal function of the other allele is 
impaired by a point mutation that results in the loss of 
the normal function of the gene product (Lane, 1992). 
Although the half-life of wild-type p53 protein of most 
cells is only 20 to 30 min, the prolonged half-life of 
mutant p53 protein allows its immunohistochemical 
detection (Levine et al., 1991). This reflects our finding 
that normal brain tissues display no significant reactivity 
with respect to p53 protein. There is evidence that 
mutant p53 protein preferentially binds to srps, 
especially the s rp  7 0  family, and forms a p53-srp 
complex that extends the protein's half-life (Pinhashi- 
Kimhi et al., 1986; Finlay et al., 1988). Although no 
direct correlation between srp 60 and p53 protein was 
statistically confirmed in primary and metastatic brain 
tumours, the observation that certain intracranial 
tumours express srp 60 showed that the p53 gene as a 
normal tumour suppressor gene was impaired. 
Although srp 60 has been detected in primary brain 
tumours and CNS metastases, the ultimate biological 
significance of these observations and their possible 
relationship to tumour behavior have not been 
established. Nevertheless, it would appear that in certain 
primary and metastatic tumours of the brain, srp 60- 
positive tumours have expressed the other five srps (90 
kDa, 72 kDa, 27 kDa, alphaB-crystallin and ubiquitin) 
with higher frequencies. In addition, there seems to be a 
tendency for the PCNA-LI to be higher in these primary 
and metastatic brain tumours that have expressed srp 60 
in a higher proportion of cells: srp 60 expression might 
depend, in part, on the proliferating potential. Whether 
these considerations apply to  brain tumours and 
metastases to the CNS, whose cells do not have normal 
proliferation control mechanisms, and how the present 
findings on srps expression and proliferating capacity of 
a given tumours are correlated, remain to be determined. 
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